CRO belong to the pharmaceutical Company (CRO b2Ph [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2022-07-08 22:18 (35 d 16:56 ago) – Posting: # 23120
Views: 459

Hi Captian ElMaestro, Helmut & all,

Should I understand that you think these kinds of studies "performed in CRO belong to the pharmaceutical Company" should be blocked and not accepted due to the high risk of COI and the possibility of manipulating the studies' outcomes.
Is there any guidance, or literature on which we can rely on it to regulate this issue?
Please kindly express your opinion clearly and frankly, it will help a lot.


Complete thread:

UA Flag
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 7 (0 registered, 7 guests [including 6 identified bots]).
Forum time: Saturday 15:15 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz